2023年代表性文章

1. Z. Wang^#, Y. Li^#, W. Zhao^#, S. Jiang^#, Y. Huang, J. Hou, X. Zhang, Z. Zhai, C. Yang, J. Wang, J. Zhu, J. Pan, W. Jiang, Z. Li, M. Ye*, M. Tan*, H. Jiang*, Y. Dang*, Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells, Signal Transduct Target Ther. 2023,8:175.

2. Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, Yuefan Zhou, Wenjing Dong, Yajing Yang, Xue Sun, Yue Dai, Yue Xu, Zhenru Zhang, Ming Xu, Qun-Ying Lei, Yanping Xu* and Lei Lv*. TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential. Cell Discovery. 2023 Aug 8; 9(1):84.

3. Zhao Zhang*, Qian Gao, Xiangmei Ren, Mei Luo, Yuan Liu, Peilin Liu, Yun Liu, Youqiong Ye, Xiang Chen*, Hong Liu*, Leng Han*. Characterization of intratumor microbiome in cancer immunotherapy. Innovation. 2023; 4(5): 100482.

4. Tao-tao Li, Duo Du, Dan-dan Zhang, Yi-cheng Lin, Jia-kang Ma, Meng-yu Zhou, Wei-da Meng, Ze-lin Jin, Zi-qiang Chen, Hao-zhe Yuan, Jue Wang, Shu-long Dong, Shao-yang Sun, Wen-jing Ye, Bo-sen Li, Hou-bao Liu, Zhao Zhang, Yu-chen Jiao, Zhi Xie, Wen-qing Qiu*, Yun Liu*. CRISPR-based targeted haplotype-resolved assembly of a megabase region. Nat Commun. 2023;14(1):22.

5. Mingen Lin, Jing He, Xinchao Zhang, Xue Sun, Wenjing Dong, Ruonan Zhang, Yanping Xu*, and Lei Lv*. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma. Journal of Clinical Investigation. 2023 May 1;133(9): e164528.

6. Cui X, Liu H, Shi T, Zhao Q, Li F, Lv W, Yu C, Huang H, Tang QQ, Pan D*. IFI27 integrates succinate and fatty acid oxidation to promote adipocyte thermogenic adaption. Adv. Sci. 2023, 10(28): e2301855.

7. Wang Y, Hong Q, Xia Y, Zhang Z*, Bo Wen*. The Lysine Demethylase KDM7A Regulates Immediate Early Genes in Neurons. Adv Sci (Weinh). 2023 Oct; 10(28):e2301367.

8. R. Wang^#, L. Xiao^#, J. Pan^#, G. Bao^#, Y. Zhu, D. Zhu, J. Wang, C. Pei, Q. Ma, X. Fu, Z. Wang, M. Zhu, G. Wang, L. Gong, Q. Tong, M. Jiang, J. Hu, M. He, Y. Wang, T. Li, C. Liang, W. Li, C. Xia, Z. Li, D.K. Ma, M. Tan, J.Y. Liu, W. Jiang*, C. Luo*, B. Yu*, Y. Dang*. Natural product P57 induces hypothermia through targeting pyridoxal kinase, Nat Commun, 2023,14 (1): 5984.

9. X. Wang^#, J. Huang^#, F. Liu, Q. Yu, R. Wang, J. Wang, Z. Zhu, J. Yu, J. Hou, J.S. Dang, YJ. Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression, J Clin Invest, 2023,133(9):e161929.

10. Yang X, Zhang Q, Li S, Devarajan R, Luo B, Tan Z, Wang Z, Giannareas N, Wenta T, Ma W, Li Y, Yang Y, Manninen A*, Wu S*, Wei GH*. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression. J Exp Clin Cancer Res. 2023, 42(1):198.

11. Ruonan Zhang#, Jie Wang#, Yu Du#，Ze Yu，Yihan Wang，Yixiao Jiang, Yixin Wu, Ting Le, Ziqi Li, Guoqiang Zhang, Lei Lv*, Haijie Ma*. CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 2023 Nov 24;11(11): e007529.

12. Meng Ding ^#, Hong-Yu Xu ^#, Wei-Yu Zhou, Yi-Fan Xia, Bai-Yu Li, Yi-Jie Shi, Xin Dou, Qi-Qi Yang, Shu-Wen Qian, Yan Tang, Dong-Ning Pan, Yang Liu*, Qi-Qun Tang*. CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305717120.

13. Tongguan Tian, Xiao Xie, Wanwan Yi, Yuefan Zhou, Yixin Xu, Yunjie Shi, Piqing Gong, Junjing Zhang, Mingen Lin, Wenjing Dong, Ruonan Zhang, Zhongwei Lv, Xinxing Li, Lei Lv*, Yanping Xu*. FBXO38 enhances cancer immunity via promoting degradation of immune checkpoint protein FGL1. Cell Reports. 2023 Nov 28;42(11):113362.

14. Tian Y, Dong D, Wang Z, Wu L, Park JY, PRACTICAL consortium,Wei GH*, Wang L*. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression. Am J Hum Genet. 2023;110(8):1289-1303.

15. Xue Sun, Yue Dai, Jing He, Hongchen Li, Xuhui Yang, Wenjing Dong, Xiao Xie*, Mingsong Wang*, Yanping Xu*, Lei Lv*. D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC. Oncogene. 2023 Nov;42(47):3503-3513.

16. Bai-Yu Li, Wan-Qiu Peng, Yang Liu, Liang Guo, Qi-Qun Tang*. HIGD1A links SIRT1 activity to adipose browning by inhibiting the ROS/DNA damage pathway. Cell Rep. 2023 Jul 25;42(7):112731.

17. Yan Tang, Li-Jie Yang, Hao Liu, Yan-Jue Song, Qi-Qi Yang, Yang Liu, Shu-Wen Qian, Qi-Qun Tang*. Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesis. Cell Rep. 2023 Jan 31;42(1):111948.

18. R.N. Wang^#, Q. Yu^#, X.B. Wang, D. Zhu, G.L. Li, Z.X. Li, W. Jiang*, W. Li*, Y.J. Dang*, Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1, Acta Pharmacol Sin. 44 (2023) 2103-2112.

19. Jiteng Fan, Jichen Sha, Shuwai Chang, Huijuan Zhao, Xiaoyun Niu, Yong Gu, Jianxin Gu*, Shifang Ren*. Generalized low levels of serum N-glycans associates with better health status. Aging Cell 2023 Jul;22(7):e13855.

20. Yuanyan Wei, Qihang Chen, Jiayue Chen, Chenhao Zhou, Shuting Geng, Danfang Shi, Sijing Huang, Zhiwei Liang, Xiaoning Chen, Ning Ren, Jianhai Jiang. Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Cell Rep. 2023 Dec 26;42(12):113588.

21. Yitong Zhao, Tao Bo, Chenfei Wang*, Dingjin Yao, Chaolan Pan, Weiyi Xu, Hao Zhou, Ming Li*, Si Zhang*. Superior TRAIL gene expression and cancer cell apoptosis mediated by highly branched-linear poly(β-amino ester)s. Journal of Nanobiotechnology. 2023 Oct 28;21(1):394.

22. Huajie Xu, Jiaojiao Zheng, Xin Zhao, Qi Zhou, Bing Fan, Hongyi Wu, Si Zhang*, Junbo Ge*. Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in 1 patients with coronary atherosclerosis disease in China: a prospective cohort study. Cardiovascular Research. 2023;119(6):1352-1360.  

23. Lv K, Sun M, Fang H, Wang J, Lin C, Liu H, Zhang H, Li H, He H,Gu Y*, Li R*, Shao F*, Xu J*. Targeting Myeloid Checkpoint Siglec-10 Reactivates Antitumor Immunity and Improves Anti-PD-1 Efficacy in Gastric Cancer. J Immunother Cancer. 2023; 11:e007669.

24. Liu X, Lv K, Wang J, Lin C, Liu H, Zhang H, Li H, Gu Y*, Li R*, He H*,Xu J*. C-type lectin receptor Dectin-1 blockade on tumor-associated macrophages improves anti-PD-1 efficacy in gastric cancer. Br J Cancer. 2023; 129(4):721-732.